Table 1 Clinical data of the preterm infants
From: Factors influencing preterm infant microbiota and their role in wheezing development
N = 91 infants | |
|---|---|
Admission in NICU | |
Sex (male) | 43 (46.7%) |
Gestational age | |
≤ 28 weeks | 22 (24.1%) |
>28 weeks | 69 (75.8%) |
Type of delivery | |
Caesarean section | 72 (78.3%) |
Vaginal birth | 20 (21.7%) |
Probiotics | 12 (13.0%) |
Antibiotics | 49 (53.8%) |
Before sample taken | 41 (45.0%) |
Risk of infection/ early-onset sepsis | 30 |
Late-onset sepsis | 11 |
Mechanical ventilation (MV) | 84 (92.3%) |
Days of MV: median (IQR) | 4 (2–12) |
BDP | 25 (27.2%) |
Viral infection | 19 (20.9%) |
Rhinovirus | 8/19 |
Coronavirus | 3/19 |
Adenovirus | 3/19 |
RSV | 1/19 |
Bocavirus | 1/19 |
Coinfections | 3/19 |
Follow up | |
Breastfed | 83 (91.2%) |
Median months of breastfed (IQR) | 6 (2.75–10) |
Wheezing episodes | 22 (23.9%) |
Less than 2 episodes | 15 (16.3%) |
More than 3 episodes | 7 (7.7%) |
Respiratory admissions | 12 (13.2%) |
Anti-asthmatic treatment | 10 (10.9%) |
Atopy (dermatitis or food allergy) | 28 (30.4%) |
